首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.
【24h】

Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.

机译:正常白蛋白尿型2型糖尿病肾病患者适当的血管修复与改善血管扩张剂后的肾灌注和功能有关。

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor: We read with great interest the article from Ritt et al entitled "Renal Vascular Endothelial Function in Hyperten- sive Patients With Type 2 Diabetes Mellitus," in which improved endothelial function of the renal vasculature was substantiated after telmisartan or ramipril therapy in 50 normoalbuminuric patients with type 2 diabetes mellitus. Such intrarenal hemodynamic improvement is supported by our recent study showing adequate vascular repair by both angiogenic (namely vascular endothelial growth factor [VEGF], angiopoietin 1, and VEGF receptor 1 [encoded by FLT1]) and antiangiogenic factors (namely angiopoietin 2 and VEGF receptor 2 [encoded by KDR]) in normoalbuminuric patients with type 2 diabetic nephropathy compared with controls (Futrakul et al, unpublished data). The improved renal hemodynamics and kidney function in this study also concur with our previous publication.
机译:致编辑:我们非常感兴趣地阅读了Ritt等人的文章“患有2型糖尿病的高血压患者的肾血管内皮功能”,其中在替米沙坦或雷米普利治疗后证实了肾血管的内皮功能得到改善。 50名2型糖尿病的正常白蛋白尿患者。我们最近的研究支持了这种肾内血流动力学改善,显示血管生成因子(即血管内皮生长因子[VEGF],血管生成素1和VEGF受体1 [由FLT1编码])和抗血管生成因子(即血管生成素2和VEGF受体)均能进行充分的血管修复与对照组相比,患有2型糖尿病肾病的正常白蛋白尿患者中2 [由KDR编码](Futrakul等人,未发表的数据)。这项研究中改善的肾脏血液动力学和肾脏功能也与我们先前的出版物一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号